The efficacy of EzeCheck device for its use in the Gynecologic department.

Not yet recruiting

• Conditions: Other obstetric conditions, not elsewhere classified,

• Registration Number: CTRI/2022/08/044952
• Lead Sponsor: Partha Pratim Das Mahapatra

Brief Summary

We want to determine the efficacy of the newly developed non-invasive device to determine the Haemoglobin levels in the female patients after the delivery , to check how accurately the device can detect the cases of post-partum anemia.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-09
• Last Update Posted: 2022-08-22

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

All female patients who have undergone delivery and prescribed for the Hemoglobin test.

Exclusion Criteria

Applied Mehndi on finger tip or have any skin disease which can affect the upper dermal layer.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Efficacy of the non-invasive device for determining the Hb levels.	4 weeks

Secondary Outcome Measures

Name	Time	Method
Efficacy of the device in detecting post-partum anemia cases.	1 month

Trial Locations

Locations (1)

KIMS; 🇮🇳 Khordha, ORISSA, India

KIMS

🇮🇳Khordha, ORISSA, India

Dr Nirmal Mohakud

Principal investigator

9437365233

nirmal.mahakud@kims.ac.in